- Home
- ADTN vs EVMN Comparison
ADTN vs EVMN Comparison
Compare ADTN & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADTN | EVMN |
|---|---|---|
| Founded | 1985 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 892.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADTN | EVMN |
|---|---|---|
| Price | $17.03 | $27.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $15.50 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 2.2M | 265.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,083,807,000.00 | N/A |
| Revenue This Year | $11.18 | N/A |
| Revenue Next Year | $9.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $7.06 | $13.89 |
| 52 Week High | $16.73 | $33.20 |
Technical Indicators
Market Signals| Indicator | ADTN | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 85.43 | 57.92 |
| Support Level | $8.38 | $21.14 |
| Resistance Level | N/A | $28.82 |
| Average True Range (ATR) | 0.68 | 1.90 |
| MACD | 0.30 | 0.32 |
| Stochastic Oscillator | 96.16 | 79.51 |
Price Performance
Historical ComparisonAbout ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.